| Application no. and date | 02801899.2 (espacenet) (Federated) (European Patent Register), 20021018 | | Patent/reg. no. and date | DK/EP 1443942, 20080102 | | Publication date | 20040811 | | Priority no. and date | US 345921 P, 20011019 | | EP pub. no. and date |
EP 1443942 20040811 | | Effective date | | | Applicant/owner | Novartis AG, Lichtstrasse 35
4056 Basel, CH,
Lipton, Allan, Penn State College of Medicine,
500 University Drive
Hershey, PA 17033, US,
Witters, Lois Mary, 25 Fisher Road
York Heaven, PA 17370, US | | Applicant ref. no. | 132788 | | Inventor | GREEN, Jonathan, Waldstrasse 12
CH-4144 Arlesheim, CH,
WITTERS, Lois, Mary, 25 Fisher Road
York Haven, PA 17370, US,
LIPTON, Allan,
Division of Oncology, Room C6830, Hersley Medical Center
Hershey, PA 17033, US | | Representative | Budde Schou A/S, Dronningens Tværgade 30, 1302 København K | | Opponent | | | IPC Class | A61K 31/335 (2006.01) , A61K 31/337 (2006.01) , A61K 31/365 (2006.01) , A61K 31/415 (2006.01) , A61K 31/42 (2006.01) , A61K 31/635 (2006.01) , A61K 31/66 (2006.01) , A61K 45/06 (2006.01) , A61P 29/00 (2006.01) , A61P 35/00 (2006.01) | | Title | Farmaceutisk sammensætning til anvendelse ved behandling af maligniteter omfattende en kombination af et bisphosphonat, en COX-2 inhibitor og en taxol | | Int. application no. | EP2002011696 | | Int. publication no. | WO2003035081 | | Related patent (certificate) | | | Status | Bortfaldet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
